Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-01

Clinical Trial Update: Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 trial on clearance of 25-hydroxyvitamin D in patients with chronic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-09-01